Funded Projects & Grants
Scientific Investment
Driving Innovation
From foundational diagnostics to Digital Animal Twins — a decade of publicly-funded breakthroughs in equine and veterinary biotechnology.
7
Funded Projects
€2.4M+
Total Eligible
€1.5M+
FEDER Approved
2011–2025
Active Period
2025 — Ongoing
CIICOH — Center for Integrative Intelligence for Co‑Creation in One Health
CENTRO2030-FEDER-02231000 · Project nº 21379
Develop exploratory scientific and technological foundations for Digital Animal Twins Sentinels, focusing on respiratory health in dogs, cats, and horses — integrating multi-source clinical, genetic, and environmental data via AI-based predictive models.
Total Eligible
€477,388
FEDER Approved
€368,040
AI Predictive Models
Digital Twins
PO_Centro — Low Density Territory
Key Results
Structured interoperable multi-source database architecture
Validated taxonomies for cross-species respiratory health
Identification of molecular and genetic biomarkers
Characterisation of respiratory RNA/DNA viruses
Strengthened R&D capacity in predictive diagnostics
Co-financed by
2019 — 2022
HoTT — Horse Testing Tour
CENTRO2030-FEDER-02231000 · Project nº 21379
Demonstrator stage supporting the first international market entry of complementary first-in-class diagnostic kits for the New Equine Virus (NEV): NEV-CHECK c-ELISA and NEV-CHECK molecular.
Total Eligible
€368,765
FEDER Approved
€235,314
NEV Diagnostics
International Markets
PO_Centro — Portugal
Key Results
Pilot production line for NEV-CHECK molecular established
Real-life validation across Europe, Brazil, and the Middle East
NEV prevalence data mapping across international cohorts
International technical support network built
Co-financed by
2015 — 2018
NEV-CHECK & EquiNEVir
Centro-01-0247-FEDER-10991
Validate the rapid diagnostic kit prototype (NEV-CHECK) in an operational environment and generate proof of concept for EquiNEVir as an antiviral therapeutic solution for the HIV-like horse virus (NEV).
Total Eligible
€453,482
FEDER Approved
€285,395
Antiviral Therapeutic
Zoonotic Potential
PO_Centro — Portugal
Key Results
Confirmed NEV tropism and cross-species zoonotic potential
Validated NEV-CHECK c-ELISA diagnostic performance
Advanced the EquiNEVir therapeutic concept
Certified pilot manufacturing assembly line established
Co-financed by
2016 — 2018
EquiNEVir — A Cure for Horse AIDS
Centro-01-0247-FEDER-17196
Submission of international PCT patent applications to protect antiviral compositions for NEV and Equine Infectious Anemia Virus (EIAV), expanding the scope of previous proprietary technologies.
Total Eligible
€95,000
FEDER Approved
€47,500
PCT Patents
EIAV Protection
PO_Centro — Portugal
Key Results
2 patent families submitted via international PCT route
10 international patent processes in national phases
Core technological assets secured in equine virology
Co-financed by
2014 — 2015
QREN 38.637 — Generation and Consolidation of a New Diagnostic Test
CENTRO-07-0202-FEDER-038637
Development of an innovative exportable ELISA diagnostic kit using specific capture peptides for the Portuguese variant of Equine Infectious Anemia Virus (AIE-2), undetectable by existing commercial tests.
Total Eligible
€404,525
Grant Approved
€230,853
ELISA Kit
AIE-2 Detection
PO_Centro — Portugal
Key Results
First specific diagnostic kit for the AIE-2 variant
Molecular and functional virus characterisation complete
International validation with USA, Brazil, France & Italy
Co-financed by
2013 — 2014
equiG2.0 — E-Commerce Platform for Equine In Vitro Diagnostic Services
CENTRO-07-0203-FEDER-031992-Inovation
Creation of a bilingual online e-commerce platform for the commercialisation and internationalisation of Equigerminal's diagnostic services, including lab equipment acquisition and CE marking.
Total Eligible
€254,228
Approved Amount
€164,650
E-Commerce
CE Certification
PO_Centro — Portugal
Key Results
equiG2.0 transaction and tracking platform launched
Laboratory quality systems expanded for CE certification
International marketing campaigns in UK, Germany & Brazil
Co-financed by
2011 — 2013
QREN 18.536 — Diagnostic Test for the Portuguese Variant of Equine Infectious Anemia
CENTRO-07-0202-FEDER-018536
Core research into novel equine lentiviruses, focusing on identification, molecular characterisation, and patenting of the specific microplate ELISA diagnostic kit (VAIE.PTest) for the chronic fatigue viral variant.
Total Eligible
€369,395
Grant Approved
€187,817
VAIE.PTest
Lentivirus Research
PO_Centro — Portugal
Key Results
Serological and genomic bank of Portuguese horses created
First molecular clone of VAIE generated
VAIE.PTest assay validated in operational conditions
Technological foundation laid for all subsequent NEV projects
Co-financed by